Evidence map›Paper›PMID 32204792›Full record

ArticleeLife2020

Rejuvenating conventional dendritic cells and T follicular helper cell formation after vaccination.

Marisa Stebegg, Alexandre Bignon, Danika Lea Hill, Alyssa Silva-Cayetano, Christel Krueger, Ine Vanderleyden, Silvia Innocentin, Louis Boon, Jiong Wang, Martin S Zand and 5 more

Open access · goldAbstract read
In one paragraph

Article in eLife, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed
4.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 70 citations in OpenAlex.

  1. Review
  2. Targeting T follicular helper cells for lifelong health.Nature reviews. Drug discovery · 2026
    Review
  3. Article
  4. What Do We Know About Immune System Aging from Human and Animal Studies?International journal of molecular sciences · 2026
    Review
  5. Review
  6. Article
  7. Review
  8. Aging restricts maturation of CXCL13bioRxiv : the preprint server for biology · 2026
    Article
  9. Article
  10. Review
  11. Immunosenescence: signaling pathways, diseases and therapeutic targets.Signal transduction and targeted therapy · 2025
    Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Review
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 4 countries.

Marisa Stebegg *Laboratory of Lymphocyte Signalling and Development, Babraham Institute, Cambridge, United Kingdom.ORCID 0000-0001-8434-8271
Alexandre Bignon *Laboratory of Lymphocyte Signalling and Development, Babraham Institute, Cambridge, United Kingdom.
Danika Lea HillLaboratory of Lymphocyte Signalling and Development, Babraham Institute, Cambridge, United Kingdom.
Alyssa Silva-CayetanoLaboratory of Lymphocyte Signalling and Development, Babraham Institute, Cambridge, United Kingdom.ORCID 0000-0003-0533-1629
Christel KruegerEpigenetics Programme, Babraham Institute, Cambridge, United Kingdom.ORCID 0000-0001-5601-598X
Ine VanderleydenLaboratory of Lymphocyte Signalling and Development, Babraham Institute, Cambridge, United Kingdom.
Silvia InnocentinLaboratory of Lymphocyte Signalling and Development, Babraham Institute, Cambridge, United Kingdom.
Louis BoonBioceros BV, Utrecht, Netherlands.
Jiong WangDivision of Nephrology, Department of Medicine and Clinical and Translational Science Institute, University of Rochester Medical Center, Rochester, United States.
Martin S ZandDivision of Nephrology, Department of Medicine and Clinical and Translational Science Institute, University of Rochester Medical Center, Rochester, United States.
James DooleyAutoimmune Genetics Laboratory, VIB and University of Leuven, Leuven, Belgium.
Jonathan ClarkBiological Chemistry, Babraham Institute, Cambridge, United Kingdom.
Adrian ListonLaboratory of Lymphocyte Signalling and Development, Babraham Institute, Cambridge, United Kingdom.
Edward CarrLaboratory of Lymphocyte Signalling and Development, Babraham Institute, Cambridge, United Kingdom.ORCID 0000-0001-9343-4593
Michelle A LintermanLaboratory of Lymphocyte Signalling and Development, Babraham Institute, Cambridge, United Kingdom.ORCID 0000-0001-6047-1996
Babraham Institute · GBUniversity of Rochester Medical Center · USKU Leuven · BEPolpharma Biologics (Netherlands) · NL

Funding

Biotechnology and Biological Sciences Research Council BBS/E/B/000C0407Biotechnology and Biological Sciences Research Council BBS/E/B/000C0408H2020 European Research Council 637801H2020 Marie Skłodowska-Curie Actions 675395
6 · The paper itself

Abstract

Germinal centres (GCs) are T follicular helper cell (Tfh)-dependent structures that form in response to vaccination, producing long-lived antibody secreting plasma cells and memory B cells that protect against subsequent infection. With advancing age the GC and Tfh cell response declines, resulting in impaired humoral immunity. We sought to discover what underpins the poor Tfh cell response in ageing and whether it is possible to correct it. Here, we demonstrate that older people and aged mice have impaired Tfh cell differentiation upon vaccination. This deficit is preceded by poor activation of conventional dendritic cells type 2 (cDC2) due to reduced type 1 interferon signalling. Importantly, the Tfh and cDC2 cell response can be boosted in aged mice by treatment with a TLR7 agonist. This demonstrates that age-associated defects in the cDC2 and Tfh cell response are not irreversible and can be enhanced to improve vaccine responses in older individuals.

Indexed as

AdolescentAdoptive TransferAdultAgedAgingAnimalsB-LymphocytesBone Marrow CellsCD11 AntigensChimeraFemaleGerminal CenterHumansImmunity, HumoralImmunologic MemoryInfluenza, HumanCD11 AntigensIfnar1 protein, mouseInfluenza VaccinesItgax protein, mouseReceptor, Interferon alpha-betaageingdendritic cellsgerminal centre responsehumanimmunologyinflammationmouset follicular helper cells

Identifiers

PMID32204792
PMCPMC7093110
OpenAlexW3012768193

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.